Brain Injury Biomarkers in the General Population

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

800 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-01-31

Study Completion Date

2011-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to use an investigational assay to assess levels of putative biomarkers of traumatic brain injury (TBI) in a general population. The data will be used in a correlative analysis with data collected under a separate study of severe TBI.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Biomarkers of Brain Injury: Magnitude and Outcome of Mild and Moderate TBI

NCT01786447

Brain Injuries, Traumatic

TERMINATED

Biomarkers of Mild and Moderate Traumatic Brain Injury

NCT01295346

Brain Injuries, Traumatic

COMPLETED

A Evaluation Of Biomarkers Associated With Sports Induced Concussions In College Student Athletes

NCT01472042

Traumatic Brain Injury Sports Concussion Sports Injury

COMPLETED

Evaluation of Biomarker Kinetics After Mild Brain Injury Trauma

NCT02541123

Traumatic Brain Injury

COMPLETED

Biomarkers of Traumatic Brain Injury With Tbit System

NCT04107662

Brain Injuries, Traumatic

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Brain Injuries, Traumatic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy Volunteers

Blood draw at Days 0, 7, 14, and 21

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood draw at Days 0, 7, 14, and 21

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* At least 18 years of age and no more than 80 years of age
* Willing to undergo consent
* PI believes volunteer is appropriate candidate for study

Exclusion Criteria

* Participating in another clinical study that may affect the results of either study
* Non-English speaking
* Venipuncture not feasible
* Blood donation within 1 week of screening
* PI determines volunteer is not medically suitable for study participation

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes